GS-US-404-1808: A Phase 2b, Dose-Ranging Study of the Ef

Project: Research project

Project Details

Description

GS-US-404-1808: A Phase 2b, Dose-Ranging Study of the Effect of GS-5745 on FEV1 in Adult Subjects with Cystic Fibrosis
StatusActive
Effective start/end date11/1/1611/1/20

Funding

  • Gilead Sciences, Inc.

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.